Megan Clark Purchases 132 Shares of CSL Limited (ASX:CSL) Stock

CSL Limited (ASX:CSLGet Free Report) insider Megan Clark purchased 132 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The shares were acquired at an average price of A$264.85 ($167.63) per share, for a total transaction of A$34,959.94 ($22,126.54).

CSL Stock Performance

The stock has a market cap of $77.43 billion, a PE ratio of 28.02, a price-to-earnings-growth ratio of 1.29 and a beta of 0.32. The company has a quick ratio of 1.68, a current ratio of 1.86 and a debt-to-equity ratio of 64.46.

CSL Increases Dividend

The business also recently disclosed a Interim dividend, which will be paid on Tuesday, April 8th. Investors of record on Tuesday, April 8th will be issued a dividend of $2.073 per share. This represents a yield of 0.81%. The ex-dividend date is Sunday, March 9th. This is an increase from CSL’s previous Interim dividend of $1.83. CSL’s dividend payout ratio (DPR) is 50.38%.

CSL Company Profile

(Get Free Report)

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.

Featured Articles

Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.